1.Spectral Analysis of Fetal Heart Rate Variability in Fetal Distress.
Yeonhee CHEON ; Dongjoo KIM ; Daeyoung CHUNG ; Kyungtae PARK ; Youngbo SHIM ; Chulseung LEW ; Sanghoon YI ; Jongchul SHIN ; Hyunggeun LEE ; Soopyung KIM
Korean Journal of Obstetrics and Gynecology 2001;44(5):845-851
OBJECTIVE: To evaluate the usefulness of power spectral analysis on fetal heart rate variability as a new diagnostic method of fetal distress. STUDY DESIGN: Among 76 pregnant women who underwent computerized electronic fetal monitoring and cord blood gas analysis, we divided them into 3 groups, i.e.; normal fetus group (36), presumed distress group (26) and acidemic distress group (14). In order to perform linear analysis on the raw data of the fetal heart rate, after resampling, we performed Fourier transformation and investigated power distributions among very low frequency (VLF), low frequency (LF), high frequency (HF) bands, and autonomic balance (LF/HF). RESULTS: The results of the spectral analysis showed that in normal fetus group, the difference in the distribution of power spectrums of VLF, LF and HF was significantly higher than in presumed distress group and acidemic distress group. In fetal distress, the LF and VLF value (0.0023, 0.0437) were good predictors (sensitivity 97.5%, 75.0% and specificity 86.1%, 94.4%). The LF value (0.0013) was a good predictor in fetal acidemia (sensitivity 97.5% and specificity 86.1%). CONCLUSIONS: A computerized spectral analysis of fetal heart rate variation is a good predictor of fetal distress, which is made automatically and objectively.
Female
;
Fetal Blood
;
Fetal Distress*
;
Fetal Heart*
;
Fetal Monitoring
;
Fetus
;
Fourier Analysis
;
Heart Rate, Fetal*
;
Humans
;
Pregnancy
;
Pregnant Women
;
Sensitivity and Specificity
2.Significance of Brain CT Angiography in Determination of Brain Death in a Patient with Barbiturate Coma Therapy after Subarachnoid Hemorrhage.
Daeyoung KIM ; Soo Kyoung KIM ; Ki Young JUNG ; Sung Tae KIM ; Chin Sang CHUNG ; Dae Won SEO
Journal of the Korean Neurological Association 2007;25(3):372-376
In determination of brain death, brain CT angiography (CTA) can be used as a new ancillary test to assist EEG which is the current gold standard. We report a patient with barbiturate coma therapy whose CTA showed weak filling of the internal carotid artery and its branches when his EEG demonstrated regional beta activities in the corresponding area, which finally disappeared. Combined use of CTA and serial EEGs would be helpful as brain death testing in a patient with barbiturate coma therapy.
Angiography*
;
Brain Death*
;
Brain*
;
Carotid Artery, Internal
;
Coma*
;
Electroencephalography
;
Humans
;
Pentobarbital
;
Subarachnoid Hemorrhage*
3.Differences in Characteristics and Comorbidity of Cluster Headache According to the Presence of Migraine
Tae Jin SONG ; Mi Ji LEE ; Yun Ju CHOI ; Byung Kun KIM ; Pil Wook CHUNG ; Jung Wook PARK ; Min Kyung CHU ; Byung Su KIM ; Jong Hee SOHN ; Kyungmi OH ; Daeyoung KIM ; Jae Moon KIM ; Soo Kyoung KIM ; Kwang Yeol PARK ; Jae Myun CHUNG ; Heui Soo MOON ; Chin Sang CHUNG ; Jin Young AHN ; Soo Jin CHO
Journal of Clinical Neurology 2019;15(3):334-338
BACKGROUND AND PURPOSE: Cluster headache (CH) can present with migrainous symptoms such as nausea, photophobia, and phonophobia. In addition, an overlap between CH and migraine has been reported. This study aimed to determine the differences in the characteristics of CH according to the presence of comorbid migraine. METHODS: This study was performed using data from a prospective multicenter registry study of CH involving 16 headache clinics. CH and migraine were diagnosed by headache specialists at each hospital based on third edition of the International Classification of Headache Disorders (ICHD-3). We interviewed patients with comorbid migraine to obtain detailed information about migraine. The characteristics and psychological comorbidities of CH were compared between patients with and without comorbid migraine. RESULTS: Thirty (15.6%) of 192 patients with CH had comorbid migraine, comprising 18 with migraine without aura, 1 with migraine with aura, 3 with chronic migraine, and 8 with probable migraine. Compared to patients with CH without migraine, patients with CH with comorbid migraine had a shorter duration of CH after the first episode [5.4±7.4 vs. 9.0±8.2 years (mean±standard deviation), p=0.008], a lower frequency of episodic CH (50.0% vs. 73.5%, p=0.010), and a higher frequency of chronic CH (13.3% vs. 3.7%, p=0.033). Psychiatric comorbidities did not differ between patients with and without comorbid migraine. The headaches experienced by patients could be distinguished based on their trigeminal autonomic symptoms, pulsating character, severity, and pain location. CONCLUSIONS: Distinct characteristics of CH remained unchanged in patients with comorbid migraine with the exception of an increased frequency of chronic CH. The most appropriate management of CH requires clinicians to check the history of preceding migraine, particularly in cases of chronic CH.
Classification
;
Cluster Headache
;
Comorbidity
;
Headache
;
Headache Disorders
;
Humans
;
Hyperacusis
;
Migraine Disorders
;
Migraine with Aura
;
Migraine without Aura
;
Nausea
;
Photophobia
;
Prospective Studies
;
Specialization
4.Smoking History and Clinical Features of Cluster Headache:Results from the Korean Cluster Headache Registry
Pil-Wook CHUNG ; Byung-Su KIM ; Jeong-Wook PARK ; Jong-Hee SOHN ; Mi Ji LEE ; Byung-Kun KIM ; Min Kyung CHU ; Jin-Young AHN ; Yun-Ju CHOI ; Tae-Jin SONG ; Dae-Woong BAE ; Daeyoung KIM ; Jae-Moon KIM ; Soo-Kyoung KIM ; Kwang-Yeol PARK ; Jae Myun CHUNG ; Heui-Soo MOON ; Kyungmi OH ; Chin-Sang CHUNG ; Soo-Jin CHO
Journal of Clinical Neurology 2021;17(2):229-235
Background:
and Purpose Epidemiologic data suggest that cluster headache (CH) is significantly associated with cigarette smoking. The aim of this study was to determine differences in features between patients with a smoking history and those who are never-smokers, using data from a prospective multicenter registry.
Methods:
Data used in this study were obtained from the Korean Cluster Headache Registry that collected data from consecutive patients diagnosed with CH. We compared clinical and demographic features between ever-smokers (current or former smokers) and never-smokers.
Results:
This study enrolled 250 patients who were diagnosed with CH, of which 152 (60.8%) were ever-smokers and 98 (39.2%) were never-smokers. The age at CH onset was significantly lower in the never-smoker group than in the ever-smoker group [27.1±12.9 years vs. 30.6± 10.9 years (mean±standard deviation), p=0.024]. Seasonal rhythmicity (58.1% vs. 44.7%, p= 0.038) and triptan responsiveness (100% vs. 85.1%, p=0.001) were higher in never-smokers, while other clinical features such as pain severity, duration, attack frequency, and associated autonomic symptoms did not differ significantly between the groups. The male-to-female ratio was markedly higher in ever-smokers (29.4:1) than in never-smokers (1.7:1).
Conclusions
Most of the clinical features did not differ significantly between patients with a smoking history and never-smokers. However, the age at CH onset, sex ratio, and seasonal rhythmicity were significantly associated with smoking history.
5.Smoking History and Clinical Features of Cluster Headache:Results from the Korean Cluster Headache Registry
Pil-Wook CHUNG ; Byung-Su KIM ; Jeong-Wook PARK ; Jong-Hee SOHN ; Mi Ji LEE ; Byung-Kun KIM ; Min Kyung CHU ; Jin-Young AHN ; Yun-Ju CHOI ; Tae-Jin SONG ; Dae-Woong BAE ; Daeyoung KIM ; Jae-Moon KIM ; Soo-Kyoung KIM ; Kwang-Yeol PARK ; Jae Myun CHUNG ; Heui-Soo MOON ; Kyungmi OH ; Chin-Sang CHUNG ; Soo-Jin CHO
Journal of Clinical Neurology 2021;17(2):229-235
Background:
and Purpose Epidemiologic data suggest that cluster headache (CH) is significantly associated with cigarette smoking. The aim of this study was to determine differences in features between patients with a smoking history and those who are never-smokers, using data from a prospective multicenter registry.
Methods:
Data used in this study were obtained from the Korean Cluster Headache Registry that collected data from consecutive patients diagnosed with CH. We compared clinical and demographic features between ever-smokers (current or former smokers) and never-smokers.
Results:
This study enrolled 250 patients who were diagnosed with CH, of which 152 (60.8%) were ever-smokers and 98 (39.2%) were never-smokers. The age at CH onset was significantly lower in the never-smoker group than in the ever-smoker group [27.1±12.9 years vs. 30.6± 10.9 years (mean±standard deviation), p=0.024]. Seasonal rhythmicity (58.1% vs. 44.7%, p= 0.038) and triptan responsiveness (100% vs. 85.1%, p=0.001) were higher in never-smokers, while other clinical features such as pain severity, duration, attack frequency, and associated autonomic symptoms did not differ significantly between the groups. The male-to-female ratio was markedly higher in ever-smokers (29.4:1) than in never-smokers (1.7:1).
Conclusions
Most of the clinical features did not differ significantly between patients with a smoking history and never-smokers. However, the age at CH onset, sex ratio, and seasonal rhythmicity were significantly associated with smoking history.